Q2 2015 Holdings
Filed 2015-08-14 | 19 holdings | $49.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Adaptimmune Therapeutics PLC(ADAPY) | SPONDS ADR | 00653A107 | $32.3M | 1,761,567 | 65.6% |
| Akebia Therapeutics Inc(AKBA) | COM | 00972D105 | $15.6M | 1,516,387 | 31.7% |
| Vanguard Index FDS(VTI) | TOTAL STK MKT | 922908769 | $318.8K | 2,979,100 | 0.6% |
| Ophthotech Corp | COM | 683745103 | $255.6K | 4,910,487 | 0.5% |
| Inogen Inc(INGN) | COM | 45780L104 | $158.3K | 3,549,320 | 0.3% |
| Wright Medical Group | CONTINGENT VALUE RIGHTS | 98235T115 | $123.9K | $4,720,065 | 0.3% |
| Vanguard Intl Equity Index F(VGK) | FTSE EUROPE ETF | 922042874 | $113.4K | 2,101,000 | 0.2% |
| Alder Biopharmaceuticals Inc(ALDR1EUR) | COM | 014339105 | $103.4K | 1,951,183 | 0.2% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $82.0K | 1,525,704 | 0.2% |
| Flexion Therapeutics Inc | COM | 33938J106 | $46.7K | 2,133,131 | 0.1% |
| Tobira Therapeutics Inc | COM | 88883P101 | $46.5K | 2,696,405 | 0.1% |
| Colucid Pharmaceuticals Inc | COM | 19716T101 | $27.2K | 3,056,563 | 0.1% |
| Otonomy Inc | COM | 68906L105 | $20.1K | 875,025 | 0.0% |
| Tokai Pharmaceuticals Inc | COM | 88907J107 | $16.5K | 1,238,252 | 0.0% |
| HTG Molecular Diagnostics Inc | COM | 40434H104 | $14.3K | 1,280,185 | 0.0% |
| Invuity Inc | COM | 46187J106 | $10.5K | 740,616 | 0.0% |
| Glaukos Corp(GKOS) | COM | 377322102 | $2.2K | 75,000 | 0.0% |
| Aerie Pharmaceuticals Inc(AERIEUR) | COM | 00771V108 | $1.8K | 100,000 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $1.5K | 127,563 | 0.0% |